Bruker (NASDAQ:BRKR) is one of today's notable stocks in decline, down 1.9% to $14.26. The S&P is currently trading fractionally higher to 1,409 and the Dow Jones Industrial Average is trading fractionally higher to 12,986.
Bruker Corporation designs, manufactures, and markets proprietary life science systems based on spectrometry technology platforms. The Company also sells a range of field analytical systems for substance detection and pathogen identification. Bruker develops life science and advanced materials research tools based on X-ray technology.
In the past 52 weeks, shares of Bruker have traded between a low of $9.91 and a high of $17.10 and are now at $14.26, which is 44% above that low price. The 200-day and 50-day moving averages have moved 0.08% lower and 0.57% higher over the past week, respectively.
Bruker has overhead space with shares priced $14.26, or 9.2% below the average consensus analyst price target of $15.70. The stock should find initial support at its 200-day moving average (MA) of $13.93 and further support at its 50-day MA of $13.25.